Orthox Announces MHRA Authorisation for Clinical Trial of Knee Cartilage Repair FibroFix™ Product Platform

/PRNewswire/ -- Orthox Limited, a clinical stage company developing medical implants to repair damaged knee articular cartilage and other orthopaedic injuries,...

Related Keywords

Germany ,Australia ,Bristol ,City Of ,United Kingdom ,Budapest ,Hungary ,China ,Oxfordshire ,France ,Australian ,Hungarian ,Nick Skaer ,Orthox Fibrofix ,Michael Whitehouse ,International Orthopaedics ,Biomedical Catalyst Fund Award ,Scius Communications ,Bristol Biomedical Research Centre ,Department Of Health ,Wellcome ,Stage Product Development ,University Of Bristol ,Oxford University ,European Innovation Council ,United Kingdom Innovation Agency ,Orthox Ltd ,National Institute For Health ,Care Research ,Agency For Healthcare Research ,Orthox Limited ,National Institute ,Wellcome Trust ,Southmead Hospital ,North Bristol ,Study Chief Investigator ,Biomedical Research Centre ,Healthcare Research ,Translation Awards ,Late Stage Product Development Awards ,Innovation Agency ,United Kingdom Aid ,Biomedical Research ,Orthox ,